Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanotypos is a nanotechnology company based in Thessaloniki, Greece, specializing in the design and large-scale manufacturing of nanostructured surfaces and devices. Founded in 2012, the company utilizes advanced Roll-to-Roll (R2R) Nanoimprint Lithography to produce high-quality, cost-effective solutions for various sectors, including biotechnology, security printing, and photonics. Their life science offerings include disposable biosensor platforms and microfluidic devices designed for rapid disease diagnostics and food screening. Nanotypos provides a full value chain of services from conceptual design and mold fabrication to pilot-scale manufacturing. The company's technology also enables the creation of biomimetic surfaces with anti-bacterial and self-cleaning properties. By democratizing nanopatterning, Nanotypos helps partners transition innovative prototype devices from laboratory scale to high-volume production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanotypos.